Horizon 2020 research project ALTERNATIVE develops an innovative platform for assessing the cardiotoxicity of chemicals. The novel platform will enable regulators and industry to identify, quantify and prevent cardiotoxic co-exposures to industrial chemicals and pharmaceuticals in a cost-effective way.
Productive meeting of ALTERNATIVE advisory board
On 19th & 20th May, ALTERNATIVE advisory board, online meeting took place. The purpose of the advisory board is to provide advice on the direction and implementation of ALTERNATIVE’s work […]
Read more
Participation of Sciensano in AOP visualisation group session organised by European Commission
On May 11th 2022, Sciensano participated in an Adverse Outcome Pathway (AOP) visualisation focus group session organized at the European Commission, Brussels, Belgium. The aim of this group session was […]
Read more
Scientific Paper on Use of Polyesters in Fused Deposition Modeling for Biomedical Applications in Macromolecular Bioscience Journal
On 30 April 2022, Partners from Politecnico di Torino published a paper on Use of Polyesters in Fused Deposition Modeling for Biomedical Applications in Macromolecular Bioscience Journal published by Wiley-VCH […]
Read more
ALTERNATIVE results presented at MicroPhysio conference in Cargèse
ALTERNATIVE consortium partner Elvesys presented selected project results at the first edition of the MicroPhysio conference on “Micro-physiological models: From organoids to organs-on-chip”, which took place at the CNRS center […]
Read more
ALTERNATIVE presented at health promotion event in Turin
ALTERNATIVE project coordinator Politecnico di Torino contributed to a regional health promotion event on the Piazza San Carlo in Turin called “Just the Woman I Am”, which took place on […]
Read more
ALTERNATIVE project introduced at European Regulators Network PARERE
At the annual European PARERE meeting on 17th February, Martin Paparella from Medical University Innsbruck and Birgit Mertens from Sciensano introduced the ALTERNATIVE project and specifically the activities related to […]
Read more
ALTERNATIVE presentation on AOPs for cardiotoxicity at 1st SAAOP Symposium
On 15, 17 and 22 February, the Society for the Advancement of Adverse Outcome Pathways (SAAOP) organized the 1st AOP Community of Practice Symposium for everybody interested in AOPs and their applications. […]
Read more
ALTERNATIVE at Kick-Off Meeting of European Green Deal Chemicals’ Cluster
On 3rd February, a kick-off cluster event was organized by European Research Agency for the projects under work programme topic “Building a low-carbon, climate resilient future: Research and innovation in […]
Read more
ALTERNATIVE presentation at PARERE workshop on regulatory requirements for cardiotoxicity data
On 21st December 2021, a joint workshop of the Austrian and Belgian networks for the ‘Preliminary Assessment of Regulatory Relevance of Alternative methods and approaches (PARERE)’ was organized online. The […]
Read more
Training session on Adverse Outcome Pathways with OECD experts
Adverse Outcome Pathways (AOPs) are a key deliverable for the regulatory uptake of the ALTERNATIVE project. But what do AOPs exactly represent? Which purpose do they serve? And how are […]
Read more